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~},~ons are responsible for 30% to 50% of the morbidity and

t¥ortality in pallents w1th system1c lupus erythematosus
~LE), and have often been cited as the primary cause of
!J'iiieath (34% to 66%).1 This is due to impaired neutrophil,
~~,:~a,Crophage/ T-cell and splenic function, complement
~Jbnonnalities and defective humoral immunity.! The risk
ft~fuetors for infection in SLE include active lupus, renal
;d}jristlfficiency, proteinuria, low albumin, use of corticosteroid
;n~-riftCimununosuppressive agent.2
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'?fJri~ study describes the spectrum of infections in SLE
:-_-~d_ -their association with the use of common
:fiifununosuppressants like corticosteroids and azathioprine.

' AU patients fulfilling the diagnostic criteria of systemic lupus
~;'erythematosus' who were admitted to The Aga Khan

; University Hospital, a tertiary care· referral center in Karachi,
:·: P~kistan, from January 1992 to January 2002 were included in
this observational study.

{aver a period of 10 years, 80 admissions (23.8%) were for
'!'management of 96 episodes of infections in 69 patients. There
. M,re67 females and 2 males with a mean age of 30.9 years
(rl\flge 8-65 years). The mean duration of lupus in these
.·.patients was 41.7 months (SO ± 57.84). Infections were
·,Jiagnosed on the basis of clinical presentation, laboratory
'.·t.sts, and cultures of blood, urine, cerebrospinal fluid and
·other relevant samples and supported by radiological
investigations. The mean duration of hospital stay for
management of infection was 5.16 days (SO± 5.24, range 1-25
d~ys). Eleven patients (15.94%) had polymicrobial infections,
· ~d infections involving more than one site. The sites of
'illfection are shown in Table I.

,.Bacterial infections accounted for more than 50% of all
:infectious episodes. Staphylococcus (S.) aureus was the commonest
~rganism isolated, followed by Escherichia coli and Klebsiella spp.
·Four patients developed tuberculosis while receiving
. 10-30 mg/ day of prednisolone; one had also received pulse
therapy with methylprednisolone 3 months before
;_developing TB.
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Sepsis due to Candida aJbicans (3) and Aspergillus flavus (1) was seen
in patients receiving 40-60 mg/ day of prednisolone. These
patients also had coexisting diabetes mellitus and renal
failure; 2 out of 4 patients with fungal infections recovered
Three patients had enteric fever and one had Salmonella
typbimurium gastroenteritis. All were on 5-10mg of prednisolone

per day for 2 2 months. Two of these patients were on
azathioprine 100 rng/ day for 2 6 months in addition to
prednisolone.
The white blood cell count (WBC) was recorded for 12 patients
out of 14 who were not on immunosuppressive therapy within
three months of development of infection. The mean WBC
count before admission was 6005/mm3, SO ± 1747, and at
the onset of infection was 11,075/mm', SO ± 8'22.7 (mean
difference 5070, SO± 7610, C.L 234.27-9905.73, p-value: 0.04,
paired Hest).
Fourteen patients had leucopenia on admission (total white
cell count <4000/mm'). Of these 2 had Herpes zoster, 2 had
malaria, 2 had cholera, and 2 had S. aureus skin infection. Tw~
patients had sepsis with Candida and BHS group A each. One
patient was significantly leucopenic (WBC<1000mm') with
WBC count of 700/mm' and absolute neutrophil count (AN C)
of 343/mm3. This patient had meningitis with cerebrospinal
fluid cultures positive for Aspergillus flavus.
The ESR was recorded only for 8 patients within the three
months prior to admission. A significant difference was found
in mean ESR before (30 mm/hr SO± 13.0) and at the onset
of infection in patients when the value was available for
comparison (91.13, so ± 40.25, mean difference 54.88, cr.
21.21-88.54, p-value: 0.006).
In 55 out of 80 admissions (68. 75o/o ), patients were on steroid
(oral prednisolone) therapy. The mean duration of steroid use
was 3.38 months (SO ± 2.23 ). The maximum number of
admissions for infections was seen in patients taking steroids
for less than 6 months, 33/80 (41.25 o/o).
No significant association was found between the steroid
dosage and number of admissions for infection. A significant
association was found between steroids dose and duration of
admission for infections; patients on higher doses of
prednisolone (30-60mg per day) had significantly longer
length of hospital stay as opposed to patients taking less than
30mg prednisolone per day (p-value 0.049 by one way
ANOVA) .
The mean duration of azathioprine therapy was 4.96 months
(SO ± 1.96). The maximum number of admissions for
Table 1: Sites of infection in SLE patients.
Infection sites
Lungs and pleura
Skin and soft tissues
Sepsis/Bacteremia
Urinary tract
Gastrointestinal tract
Bone and joints
Central nervous system /meninges
Throat and ear
Endometrium

Number of infections (96)

24
17

16
15

8
8
6

625

infections was seen in patients taking azathioprine for less
than 6 months (13/80, 16.25%) and 2 each for patients on
therapy for 6-12 and 12-24 months.

methylprednisolone pulse therapy on the risk for infe .
The role of azathioprine in predisposing to infecti Ction.t
remains unclear.
on also

No correlation was found between infection and dose and
duration of azathioprine.

The outcome of infectiqns in these patients was ge
favorable and a significant majority (81.15%) was sentn~ra~
0
after initial in-hospital management of their infection. Se 11\'
infections developed in patients with SLE of more than 3 nou,
duration, most of whom were not taking more than lOmgj~~
of prednisolone for less than 6 months. Only a Y
1
patients were on concomitant high dose azathiop •w
.
. these patients,
.
These observahons
suggest that m
infections
developed most likely as a consequence of irnm
abnormalities due to the disease itself with only a rn:;,n,
.
fr om concomitant
.
contn'bu t10n
use of routine immu or

Fourteen patients (20.28%) were not on any immunosuppressive agents at the time of admission for infection.
Thirteen out of 69 patients (18.84 %) died during the course of
infection. The rest were discharged home on appropriate
antimicrobial therapy.
Most infections in the study patients were due to common
bacteria like Escherichia coli and Staphylococcus aureus. However, some
cases of tuberculosis, malaria, salmonellosis and cholera were

also seen. Increased incidence of salmonellosis has been
described in SL£5 and infections by non-typhoidal Salmorwlla
occur mainly in those SLE patients who have lower levels of
complement, splenic dysfunction and those receiving
immunosuppressive therapy.6 Mycobacteria, esp. M. tuberculosis
are important opportunistic infections in SLE patients,
particularly in endemic countries.' Serious mycobacterial
infection necessitating hospitalization occurred in 4 patients
and was caused exclusively by Mycobacten'um tuberculosis, a
reflection of disease endemicity.

Fungal infections occur frequently in SLE patients receiving
high doses of corticosteroids or immunosuppressive
therapy.s Fungal infections accounted for 4% of all infectious
episodes in our patients. Aspergillus jlavus meningitis, a rare
infection, was seen in a patient who was neutropenic and on
high doses of corticosteroids. Herpes zoster, the most
frequent viral infection reported in SLE 8,9 occurs mainly in
patients with previous histories of nephritis, hemolytic

.

no.

suppressants used to control the diSease. Use of higher do
of steroids did not appear to predispose to infections requi:
hospitalization but did increase the length of hospital stag
Increased predisposition to infection was not seen in patieni'
on high doses of azathioprine.
s
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